Efficacy and safety of Janus kinase 1/2 inhibitor KL130008 in active rheumatoid arthritis: a randomized, double-blind, placebo-controlled phase II trial
Registered in the Chinese Clinical Trial Register (ChiCTR2100042141).
Publications
1 shownFrequent Co-Authors
Researcher Info
- h-index
- 0
- Publications
- 1
- Citations
- 0
- Institution
- Affiliated Hospital of Liaoning University of Traditional Chinese Medicine
External Links
Identifiers
- ORCID
- 0000-0002-3208-0821
Impact Metrics
h-index
0
h-index: Number of publications with at least h citations each.